- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05668442
Feasibility of an Online Exercise Community Among Individuals With Type 2 Diabetes
Online Physical Exercise and Group Sessions to Increase and Maintain Physical Activity in Individuals With Type 2 Diabetes: A Single-Arm Feasibility Study
Study Overview
Status
Intervention / Treatment
Detailed Description
The study is designed as a one-armed feasibility for the reason that the progression criteria are linked to the intervention. No blinding will be applied in the study.
The study will be carried on the Centre for Physical Activity Research, Rigshospitalet, Denmark. Reporting of the study will be following the CONSORT extension to a randomized pilot and feasibility trials.
Participants will be recruited from the Capital Region of Denmark and Region Zealand using different recruitment strategies followed by a telephone screening with the project coordinator.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
København N
-
Copenhagen, København N, Denmark, 2200
- Center for Physical Activity Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosed with type 2 diabetes
- Access to a device such as a computer, tablet, or a smart phone
Exclusion Criteria:
- Contraindications to exercise, for example heart conditions, complications/injuries in the locomotive apparatus
- Advised to not exercise by medical doctor
- Current participation in other intervention trials
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participant Recruitment
Time Frame: 3 months
|
Evaluation of participant recruitment was made by calculating number of participants recruited within three months.
|
3 months
|
Completion of intervention
Time Frame: 10 weeks
|
Evaluation of completion of the intervention was made by calculating the percentage of participants who provided baseline and postintervention data out of the total number of participants at baseline
|
10 weeks
|
Adherence to online physical exercise
Time Frame: 8 weeks
|
Evaluation of adherence to online physical exercise, participants received weekly web-based questionnaires instantly after the online physical exercise to respond whether they attended the session. Adherence to online physical exercise was calculated by counting the number of completed online meetings separately, divided by the eight planned sessions. |
8 weeks
|
Difficulty in participating in the objectively measured physical activity
Time Frame: 8 weeks
|
Difficulty in participating in the objectively measured physical activity was evaluated with a questionnaire at postintervention regarding participants' satisfaction with applying and wearing the accelerometers during the intervention
|
8 weeks
|
Adverse events
Time Frame: 8 weeks
|
Evaluation of adverse events involved experienced severity of adverse events in the postintervention questionnaire according to the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®). Minor adverse events covered dizziness, acute and prolonged musculoskeletal pain, and minor falls. Serious adverse events covered life-threatening events, disability, permanent damage, or hospitalization |
8 weeks
|
Research Progression Criteria
Time Frame: 8 weeks
|
Research Progression Criteria obtained through self-reported data from weekly questionnaires organized into the following categories: Participant recruitment Completion of intervention Adherence to online physical exercise Adherence to the group meeting Adherence to goal setting Difficulty in participating in the objectively measured physical activity Improvement of physical activity Adverse events |
8 weeks
|
Adherence to online meeting
Time Frame: 8 weeks
|
Evaluation of adherence to online group meetings, participants received weekly web-based questionnaires instantly after the online meeting to respond whether they attended the session. Adherence to online meeting was calculated by counting the number of completed online meetings separately, divided by the eight planned sessions. |
8 weeks
|
Adherence to goal setting
Time Frame: 8 weeks
|
During the 8-week intervention, participants wrote down a weekly activity goal for the forthcoming week and if they completed the activity goal from the previous week.
|
8 weeks
|
Improvement of physical activity
Time Frame: 8 weeks
|
Evaluation of improvement of habitual physical activity, all participants wore axivity (AX3) (Axivity, Newcastle, UK) accelerometers for seven consecutive days before, during and after the intervention.
Accelerometer data was considered valid if the participant had minimum 22 hours wear time out of 24 possible.
A measurement period was considered valid, if the participant had at least three valid weekdays and one valid weekend day.
Any improvement in habitual physical activity (daily counts per minute) from baseline to postintervention was considered as an improvement
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Questionnaires
Time Frame: 8 weeks
|
|
8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mathias R Larsen, PhD, Center for Physical Activity Research, Copenhagen University Hospita
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-21062951
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
AstraZenecaRecruiting
Clinical Trials on Online exercise and group meetings
-
Mehmet Akif Ersoy UniversityAkdeniz UniversityCompletedExercise Program | Type2diabetesTurkey
-
Helsinki University Central HospitalUniversity of Helsinki; Occupational Health HelsinkiActive, not recruiting
-
Aristotle University Of ThessalonikiCompletedCardiovascular DiseasesGreece
-
Universitat Jaume IRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedProstate CancerUnited States
-
Johns Hopkins UniversityCompleted
-
Université Catholique de LouvainRecruitingMultiple Chronic ConditionsBelgium
-
Meir Medical CenterCompletedOsteoarthritis | Low Back PainIsrael
-
Duke UniversityActive, not recruitingPreterm BirthUnited States
-
Ruhr University of BochumCompleted